CURCIO v. CCS MEDICAL, INC.

CourtDistrict Court, D. New Jersey
DecidedJune 30, 2023
Docket2:19-cv-05527
StatusUnknown

This text of CURCIO v. CCS MEDICAL, INC. (CURCIO v. CCS MEDICAL, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CURCIO v. CCS MEDICAL, INC., (D.N.J. 2023).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

FREDERICK D. CURCIO, IV ex rel. Civil Action No. UNITED STATES OF AMERICA, 19-5527 (SDW) (LDW) Plaintiffs, MEMORANDUM OPINION AND v. ORDER OF TRANSFER

CCS MEDICAL, INC., DEGC

ENTERPRISES (U.S.), INC.,

HIGHLAND CAPITAL

MANAGEMENT, LP, MEDICAL

EXPRESS DEPOT, INC., MEDSTAR

DIABETIC SUPPLY, LP, MP

TOTALCARE MEDICAL, INC., and MP TOTALCARE SERVICES, INC.,

Defendants.

LEDA DUNN WETTRE, United States Magistrate Judge

Before the Court is the motion of Plaintiff-Relator Frederick D. Curcio, IV (“Relator”) to transfer venue of this action to the Northern District of Texas pursuant to 28 U.S.C. § 1404(a). (ECF No. 37).1 Defendants CCS Medical, Inc., DEGC Enterprises (U.S.) Inc., Medical Express Depot, Inc., MedStar Diabetic Supply, LP, MP Totalcare Services, Inc., and MP Totalcare Medical, Inc. (collectively, “Defendants”), through their counsel, oppose transfer entirely, and argue in the alternative that if the action is to be transferred, the Middle District of Florida is the appropriate

1 On June 20, 2023, Relator filed a motion to withdraw this transfer motion. (ECF No. 65). Subsequently, on June 27, 2023, Relator renewed the instant motion to transfer venue and asked the Court to disregard the motion to withdraw the motion. (ECF No. 70). On the same date, the undersigned convened a telephonic conference with counsel for the parties, during which counsel for both sides reiterated the positions set forth in their briefing of this Motion to Transfer. (ECF Nos. 37, 55, 58). The Court, accordingly, adjudicates the instant motion without regard to that intervening filing, which, having been withdrawn by Relator (ECF No. 70) shall be terminated. transferee court. (ECF No. 55).2 The Court decides the Motion without oral argument pursuant to Rule 78 of the Federal Rules of Civil Procedure.3 Having considered the parties’ written submissions (ECF Nos. 37, 55, 58), and for the reasons set forth below, Relator’s Motion is GRANTED. The Court, therefore, in its discretion, will transfer this action pursuant to 28 U.S.C. § 1404(a) to the

United States District Court for the Northern District of Texas. I. BACKGROUND Relator initiated this qui tam action in this Court on February 11, 2019, seeking to recover damages and civil penalties on behalf of the United States for Defendants’ alleged violations of the False Claims Act, 31 U.S.C. § 3729, et seq. (“FCA”), the Civil Monetary Penalties Law, 42 U.S.C. §§ 1320a-7a, and the Program Fraud Civil Remedies Act, 31 U.S.C. §§ 3801-3812. (Complaint, ECF No. 1 at 1). Relator is a resident of Texas and former Dallas, Texas-based employee of Defendant CCS. (ECF No. 37-1 at 6, 10). Defendants are related entities engaged in the medical supply business “focused on diabetic, wound care, ostomy, and urological durable medical equipment, prosthetics, orthotics, and supplies (‘DMEPOS’).” (ECF No. 37-1 at 6). Each of the defendant entities is

incorporated outside of New Jersey – in Delaware, Florida, Texas, Pennsylvania, Colorado, and

2 Relator advises that the United States, which declined to intervene in the action but is named as a party in interest, has consented to transfer to the Northern District of Texas. (See ECF Nos. 37- 1 at 5 n.1; 58 at 3). Relator additionally advises that Highland Capital Management, LP, which was named in the Complaint but has never appeared in the action, has indicated that it does not oppose transfer to that proposed transferee court, though it maintains the claims against it must be brought, once transferred, in the Northern District of Texas Bankruptcy Court. (ECF No. 37-1 at 5 n.1). 3 The undersigned issues this Memorandum Opinion in lieu of a Report and Recommendation because the relief sought in this motion is not dispositive of any claim or defense asserted in the action. Fed. R. Civ. P. 72. See, e.g., Vuoncino v. Forterra, Inc., Civ. A. No. 18-02437 (CCC) (ESK), 2021 WL 1589356 (D.N.J. Apr. 22, 2021) (treating transfer as non-dispositive); Griggs v. Swift Transportation Co., Civ. A. No. 217-13480 (MCA)(SCM), 2018 WL 3966304, at *2 n.15 (D.N.J. Aug. 17, 2018) (same); Stalwart Capital, LLC v. Warren St. Partners, LLC, No. 11-5249, 2012 WL 1533637, at *1 (D.N.J. Apr. 30, 2012) (same). Georgia, respectively – and each maintains its principal place of business in Farmers Branch, Texas, a suburb outside of Dallas. (See Am. Compl., ECF No. 18 ¶¶ 16-21). In the Complaint, Relator alleges Defendants defrauded the United States, as well as several states, by submitting false claims worth many millions of dollars to federal and state government health programs. (See id. ¶¶ 1-13).

The United States investigated the claims asserted in the Relator’s Complaint and, on July 2, 2021, notified the Court of its election to decline to intervene in the action pursuant to the FCA. 31 U.S.C. § 3730(b)(4)(B). (ECF No. 8). Accordingly, the case was unsealed, and the docket filings became publicly available. (See id.). Relator filed an Amended Complaint on November 17, 2021. (ECF No. 18). The United States, on behalf of itself and each State named as an interested party in the action, filed a notice of election to decline intervention in the Amended Complaint on October 12, 2022. (ECF No. 24). By Order of October 13, 2022, the Hon. Susan Davis Wigenton, U.S.D.J., unsealed the Amended Complaint, which the Relator then served upon Defendants. (ECF Nos. 25- 29).4 Defendants moved to dismiss on February 7, 2023, on grounds that the Amended Complaint contains impermissible group pleading, lacks sufficient particularity under Federal Rule of Civil

Procedure 9(b), and fails to state a claim under Federal Rule of Civil Procedure 12(b)(6). (ECF No. 36). Relator filed the instant Motion to Transfer Venue on February 13, 2023. (ECF No. 37). The Court convened a case management conference on March 7, 2023, during which the undersigned solicited from the parties their positions as to the appropriate order of adjudication of the Motion to Dismiss and Motion to Transfer. Having considered the parties’ respective views as set

4 The record reflects that Defendant Highland Capital Management, L.P. was never served with the initial Complaint or Amended Complaint and, therefore, has never appeared in this action. (See ECF No. 55 at 1 n.1, 5; Exh. A, ECF No. 55-1). Although the parties argue extensively with regard to the views of this entity on the proposed transfer, Highland Capital Management, L.P. has submitted to the Court no formal position on the motion, nor has it otherwise participated in this action. The Court therefore adjudicates the instant motion without regard to the unbriefed views of this entity. forth in the letters at ECF Nos.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gulf Oil Corp. v. Gilbert
330 U.S. 501 (Supreme Court, 1947)
Van Dusen v. Barrack
376 U.S. 612 (Supreme Court, 1964)
Ricoh Co., Ltd. v. Honeywell, Inc.
817 F. Supp. 473 (D. New Jersey, 1993)
Schering Corp. v. First Databank, Inc.
479 F. Supp. 2d 468 (D. New Jersey, 2007)
Rappoport v. Steven Spielberg, Inc.
16 F. Supp. 2d 481 (D. New Jersey, 1998)
In Re Howmedica Osteonics Corp.
867 F.3d 390 (Third Circuit, 2017)
Reading Health System v. Bear Stearns Co Inc
900 F.3d 87 (Third Circuit, 2018)
Shutte v. Armco Steel Corp.
431 F.2d 22 (Third Circuit, 1970)

Cite This Page — Counsel Stack

Bluebook (online)
CURCIO v. CCS MEDICAL, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/curcio-v-ccs-medical-inc-njd-2023.